newsfilter
← Latest News
GlobeNewswire·

Miromatrix Applauds the FDA for Its Continued Commitment to the Field of Organ Transplant

EDEN PRAIRIE, Minn., July 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ:MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, applauds the U.